Document is current
Any future updates will be listed below
-
Authors
da Silva, Jéssica Malena Pedro
Araújo, Raul Denner Duarte
da Silva Santos, Francisca Cristina
Fabro, Erica Alves Nogueira
de Mello Pinto, Marcus Vinicius
de Aguiar, Suzana Sales
Thuler, Luiz Claudio Santos
Bergmann, Anke https://orcid.org/0000-0002-1972-8777
- License Information
-
More Information
Article History
Received: 21 December 2022
Accepted: 13 June 2023
First Online: 22 August 2023
Declarations
:
: This project was approved by the research ethics committee (REC) of the Brazilian National Cancer Institute (INCA) by n° 4611711 on March 25, 2021, and subsequently registered in Clinical Trials (NCT04934098-phase 1; NCT04881604-phase 2). Changes in the research protocol, evaluations, and number of participants in the study will be informed and evaluated by the research ethics committee.All eligible patients will be invited to participate and, at that time, will be informed about the study objectives, risks, and benefits of voluntary participation and that they may request to leave the study free of charge at any time. Participants will only enter the study after accepting and signing a free and informed consent form (FICF). All information will be stored in a database, protected, and kept confidential, with access only by the study researchers.
: Item not applicable, as this manuscript does not contain information or individual personal data of study participants.
: The authors declare a conflict of interest due to the donation of the compressive material used in the study by VENOSAN BRASIL LTDA. Despite this, the company does not present any associations that allow it to favorably change the results of this study to its interests. Therefore, the authors guarantee that they have complete freedom to publish the data.
